Notices. DEPARTMENT OF JUSTICE
373 words·~2 min read·
/register/2012/08/20/2012-20369·A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
BILLING CODE 4410-09-P DEPARTMENT OF JUSTICE Drug Enforcement Administration Importer of Controlled Substances; Notice of Registration; Research Triangle Institute Correction In notice document 2012-19208 appearing on pages 47111-47114 in the issue of Tuesday, August 7, 2012, make the following correction: On page 47111, in the second column, the document heading should appear as set forth above. [FR Doc. C1-2012-19208 Filed 8-17-12; 8:45 am] BILLING CODE 1505-01-D DEPARTMENT OF JUSTICE Drug Enforcement Administration Importer of Controlled Substances;
Notice of Registration; Catalent Pharma Solutions, Inc. Correction In notice document 2012-19202 appearing on page 47114 in the issue of Tuesday, August 7, 2012, make the following correction: On page 47114, in the first column, the document heading should appear as set forth above. [FR Doc. C1-2012-19202 Filed 8-17-12; 8:45 am] BILLING CODE 1505-01-D DEPARTMENT OF JUSTICE Drug Enforcement Administration Manufacturer of Controlled Substances, Notice of Registration, Cody Laboratories, Inc.
By Notice dated March 8, 2012, and published in the **Federal Register** on March 20, 2012, 77 FR 16263, Cody Laboratories, Inc., 601 Yellowstone Avenue, Cody, Wyoming 82414, made application by letter to the Drug Enforcement Administration
(DEA)to be registered as a bulk manufacturer of the following basic classes of controlled substances: Drug Schedule 4-Anilino-N-phenethyl-4-piperidine
(8333)II Thebaine
(9333)II The company plans on manufacturing the listed controlled substances as bulk intermediates for distribution to its customers. No comments or objections have been received. DEA has considered the factors in 21 U.S.C. 823(a) and determined that the registration of Cody Laboratories, Inc. to manufacture the listed basic classes of controlled substances is consistent with the public interest at this time. DEA has investigated Cody Laboratories, Inc. to ensure that the company's registration is consistent with the public interest. The investigation has included inspection and testing of the company's physical security systems, verification of the company's compliance with state and local laws, and a review of the company's background and history. Therefore, pursuant to 21 U.S.C. 823, and in accordance with 21 CFR 1301.33, the above named company is granted registration as a bulk manufacturer of the basic classes of controlled substances listed. Dated: August 7, 2012. Joseph T. Rannazzisi, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. [FR Doc. 2012-20369 Filed 8-17-12; 8:45 am]
Connectionstraces to 2
Traces to 2 documents
Citation graph
cites case law
Cites 2Cited by 0 across 0 sources